#Diagnostics #Virtual Reality
- Virtual reality
- Artificial Intelligence
- Cardiology
- Electrophysiology
- Visualization
As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.
Discover >Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.
Discover >Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.
Discover >Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.
Discover >#Diagnostics #Virtual Reality
VRAI-Heart offers unprecedented intuitive, real-time navigation, enabling complete immersion in an extremely precise heart model, personalized for each patient, thanks to a combination of virtual reality and artificial intelligence.
BACKGROUND
VRAI-Heart was born in 2021 within Evry’s Genopole ecosystem. The project continued its development thanks to two programs: Genopole’s Shaker and Institut Imagine Biolaunchpad Entrepreneur, along with an incubation at Cluster C19. A cross-functional team gathered to create the company in June 2024. This was followed by a patent application in July of the same year. Since September, there have been a number of significant events demonstrating interest in the solution. VRAI-Heart first became a prizewinner in Genopole’s GENE.io program, then obtained the DEEPTech label from BPI France, and finally won the “Digital Start-up Trophy” from IMT Starterr.
DESCRIPTION OF PRODUCTS / SERVICES / TECHNOLOGY
VRAI-Heart is an AI-enhanced virtual reality and motion tracking medical device. It combines preoperative imaging (scans) and real time intraoperative data in order to offer intuitive navigation and more precise targeting thanks to immersive virtual reality, hence improving cardiac ablation procedures.
CUSTOMER REFERENCES / COLLABORATIONS / HIGHLIGHTS
– 17/06/2024 Incorporation
– 11/07/2024 Patent filed
– 13/09/2024 Évry’s Genopole GENE.io laureate
– 01/10/2024 DeepTech label obtained from BPI France
– 14/11/2024 BPI France Deeptech grant obtained
– 10/12/2024 Winner Digital Start-up Trophy from IMT Starter
COLLABORATIONS SOUGHT
– Experimentation-oriented hospital departments
– Motion tracking specialists
– 3D modeling and printing experts
1 patent
1 employee
STRENGHTS
Large growing market, high unmet medical need with high impact on public health ; experienced team. Unique solution, scalable and with high barriers to entry.
INNOVATION ASSETS
unique combination of digital twin 3D modeling, virtual reality and motion tracking
In the same field